Scarica l'app Stockscreener
1.62
13.19%
0.18
Pulmonx Corp Borsa (LUNG) Ultime notizie
LUNG: Analyst Jason Kolbert Maintains 'Buy' Rating with $14 Targ - GuruFocus
Pulmonx (NASDAQ:LUNG) Given "Buy" Rating at D. Boral Capital - MarketBeat
Pulmonx Secures $60 Million Senior Secured Term Loan From Perceptive; $40 Million Drawn - TradingView
Pulmonx Corp (LUNG) Q4 2025 Earnings Call Highlights: Strategic - GuruFocus
Pulmonx (NASDAQ:LUNG) Insider Sells $11,056.76 in Stock - MarketBeat
Pulmonx Q4 Earnings Call Highlights - Yahoo Finance
Pulmonx Corporation (LUNG) Posts Fourth Quarter Loss, Surpasses Revenue Projections - Bitget
Pulmonx closes $60M credit facility with Perceptive Advisors - Investing.com
Pulmonx closes $60 million credit facility with Perceptive - Investing.com
Earnings call transcript: Pulmonx Q4 2025 EPS beats, revenue misses, stock dips - Investing.com Canada
Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Pulmonx (LUNG) Exceeds Q4 Revenue Expectations with Strategic Gr - GuruFocus
Pulmonx (LUNG) Projects 2026 Financial Outlook with Revenue and Margin Targets - GuruFocus
Pulmonx earnings beat by $0.14, revenue fell short of estimates - Investing.com
Pulmonx Corporation Reports Fourth Quarter and Full Year 2025 Financial Results, Highlights Transition and Strategic Focus for 2026 - Quiver Quantitative
Earnings Summary: Pulmonx Q4 - Benzinga
Lung device maker Pulmonx trims losses, guides 2026 sales to $90–92M - Stock Titan
Pulmonx Announces Closing of up to $60 Million Credit Facility - Yahoo Finance
Earnings Preview For Pulmonx - Benzinga
LUNG Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
LUNG Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
LUNG Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 - Bitget
Analyst Jason Kolbert Maintains Buy Rating for Pulmonx (LUNG) at $14 Target | LUNG Stock News - GuruFocus
Pulmonx's (LUNG) "Buy" Rating Reiterated at D. Boral Capital - MarketBeat
Pulmonx Corporation to Announce Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 - Quiver Quantitative
Pulmonx Stock Pops on Takeover Deal: Cash Exit or Hold Out? - AD HOC NEWS
Pulmonx Corporation (NASDAQ:LUNG) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Will Pulmonx Corporation stock outperform Dow Jones index2025 Biggest Moves & Daily Growth Stock Investment Tips - mfd.ru
Pulmonx Stock Under Pressure: Can A Niche Lung-Health Innovator Breathe New Life Into Its Shares? - AD HOC NEWS
Will Pulmonx Corporation stock beat EPS estimatesWeekly Risk Summary & Stock Portfolio Risk Control - mfd.ru
Pulmonx (LUNG) Expected to Announce Earnings on Wednesday - Defense World
Merger Talk: Is Pulmonx Corporation a good ESG investment2025 Key Highlights & Free Community Consensus Stock Picks - baoquankhu1.vn
Pulmonx Aktie: Zahlen im Fokus - Börse Global
Pulmonx Q4 2025 Results: A Litmus Test for New Leadership - AD HOC NEWS
Sentiment Watch: Is Pulmonx Corporation a turnaround story2025 Technical Patterns & Weekly Top Gainers Alerts - baoquankhu1.vn
US Market Wrap: Can Cabaletta Bio Inc disrupt its industryJuly 2025 Outlook & Reliable Entry Point Alerts - baoquankhu1.vn
Analyzing Pulmonx (NASDAQ:LUNG) and Privia Health Group (NASDAQ:PRVA) - Defense World
Aug Rallies: How Pulmonx Corporation stock compares to growth peersJuly 2025 Gainers & Reliable Volume Spike Alerts - Bộ Nội Vụ
Why The Pulmonx LUNG Narrative Is Shifting After Target Cut And Leadership Return - Yahoo Finance
Is Pulmonx Corporation stock vulnerable to regulatory risks2025 Price Targets & Weekly High Potential Alerts - Улправда
How Pulmonx Corporation stock valuations compare to rivalsTrade Performance Summary & AI Driven Stock Price Forecasts - Улправда
Pulmonx Corporation (NASDAQ:LUNG) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Pulmonx Corporation (NASDAQ:LUNG) Given Consensus Rating of “Hold” by Brokerages - Defense World
How Leadership Changes And Analyst Revisions Are Shaping Pulmonx's Valuation Story - Yahoo Finance
Pulmonx (NASDAQ:LUNG) Trading Up 2.5%Here's What Happened - MarketBeat
EBITDA per share of Pulmonx Corp. – GETTEX:4NI - TradingView — Track All Markets
What technical charts say about Pulmonx Corporation stockWeekly Stock Summary & AI Enhanced Trade Execution Alerts - Улправда
Why Pulmonx Corporation stock is in analyst buy zoneJuly 2025 PreEarnings & AI Driven Stock Reports - Улправда
Can Pulmonx Corporation stock hit analyst price targetsDay Trade & Reliable Price Action Trade Plans - Улправда
How strong is Pulmonx Corporation stock revenue growthQuarterly Trade Report & Short-Term High Return Ideas - Улправда
Can Pulmonx Corporation stock resist sector downturnsJuly 2025 Drop Watch & Breakout Confirmation Alerts - Улправда
Will Pulmonx Corporation stock deliver better than expected guidanceJuly 2025 Closing Moves & Community Trade Idea Sharing - Улправда
How Pulmonx Corporation stock performs in interest rate cyclesJuly 2025 Patterns & High Conviction Investment Ideas - Улправда
Will Pulmonx Corporation stock continue upward momentumJuly 2025 Opening Moves & Stepwise Trade Signal Guides - Улправда
Pulmonx Navigates Leadership Shift Amidst Mixed Financial Results - AD HOC NEWS
What New Catalysts Are Shifting the Pulmonx Story for Investors - Yahoo Finance
Comparing Careview Communications (OTCMKTS:CRVW) and Pulmonx (NASDAQ:LUNG) - Defense World
Insider Selling: Daniel Florin Sells Shares of Pulmonx Corp (LUN - GuruFocus
Pulmonx Corp Director Daniel P Florin Sells 23,321 Shares - TradingView — Track All Markets
2.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):